
Professional Bio:
Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT(hon) is the Immediate Past President of the American Society for Preventive Cardiology. She is a professor of cardiology at the Smidt Heart Institute at Cedars Sinai in Los Angeles and is the director of prevention, the associate director of the Barbra Streisand Women's Heart Center and holds the Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research. She was formerly the inaugural Chief of Cardiology at the University of Arizona. She is the author of the best-seller, “Saving Women’s Hearts”. She served as the chair of the national chest pain guidelines from the American Heart Association and the American College of Cardiology. She also served as editor-in-chief of CardioSmart, the patient education arm of the American College of Cardiology. Her exceptional commitment to the study of women and cardiac diseases has won her numerous awards and distinctions, including being named by Crain’s Chicago Business as one of Chicago’s Top 40 under 40. In 2011, she received the first CREDO (Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Outcomes) Award from the American College of Cardiology that was given to honor her contributions to improve cardiovascular healthcare of women patients. In 2012, she was awarded the National Red Dress Award for her efforts in raising awareness of heart disease in women and advancing research in this field. In 2019, she was chosen as the most influential woman in Arizona and received the 2019 American College of Cardiology’s Bernadine Healy Award for her leadership and accomplishment in the field of cardiovascular disease in women. In 2023, she was awarded the Arthur Agatston Award in Cardiovascular Disease prevention from the Society of Cardiovascular Computed Tomography (SCCT). She is the principal investigator of the St. James Women Take Heart Project, a study that examined cardiac risk factors in women, and set standards for women’s fitness levels and heart rate response to exercise. She is the site PI and coinvestigator of the WARRIOR (Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD) trial that is funded by the Department of Defense. She also is a co-investigator on the Women Ischemic Syndrome Evaluation (WISE) study and previously served as a co-investigator on the Women’s Health Initiative (WHI). She has published articles in peer-reviewed publications, including The New England Journal of Medicine, Circulation, and Journal of the American Medical Association (JAMA). She has also been featured on Oprah. Dr. Gulati is Canadian and completed medical school at the University of Toronto, Canada. She went on to complete her internship, residency and cardiology fellowship at the University of Chicago. She received a Masters’ in Science at the University of Chicago and is a fellow of the American College of Cardiology, the American Heart Association, the American Society for Preventive Cardiology & the European Society of Cardiology. She is board certified in cardiovascular disease.
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Esperion(MODEST) SPEAKER'S BUREAU: Siemans(SIGNIFICANT) OFFICER, DIRECTOR ETC: American Society of Preventive Cardiology(NONE)